Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

IES Holdings (IESC) Asset Writedowns and Impairment: 2009-2025

Historic Asset Writedowns and Impairment for IES Holdings (IESC) over the last 16 years, with Sep 2025 value amounting to $2.8 million.

  • IES Holdings' Asset Writedowns and Impairment rose 186.04% to $2.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.4 million, marking a year-over-year increase of 132.61%. This contributed to the annual value of $3.4 million for FY2025, which is 132.61% up from last year.
  • Per IES Holdings' latest filing, its Asset Writedowns and Impairment stood at $2.8 million for Q3 2025, which was up 568.12% from $414,000 recorded in Q2 2025.
  • IES Holdings' Asset Writedowns and Impairment's 5-year high stood at $2.8 million during Q3 2025, with a 5-year trough of -$600,000 in Q3 2023.
  • For the 3-year period, IES Holdings' Asset Writedowns and Impairment averaged around $431,182, with its median value being $225,000 (2024).
  • Per our database at Business Quant, IES Holdings' Asset Writedowns and Impairment skyrocketed by 11,033.33% in 2022 and then crashed by 241.18% in 2023.
  • IES Holdings' Asset Writedowns and Impairment (Quarterly) stood at $92,000 in 2021, then crashed by 31.52% to $63,000 in 2022, then soared by 138.10% to $150,000 in 2023, then surged by 50.00% to $225,000 in 2024, then surged by 186.04% to $2.8 million in 2025.
  • Its Asset Writedowns and Impairment stands at $2.8 million for Q3 2025, versus $414,000 for Q2 2025 and $40,000 for Q1 2025.